Natus Medical, Inc. (BABY) Misses Q4 EPS by 1c, Offers Q1 and FY12 Outlook

Natus Medical, Inc. (NASDAQ: BABY) reported Q4 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $64.1 million versus the consensus estimate of $64.97 million.

Natus Medical, Inc. sees Q1 2012 EPS of $0.00-$0.07, versus the consensus of $0.07. Natus Medical, Inc. sees Q1 2012 revenue of $55-$60 million, versus the consensus of $60.2 million.

Natus Medical, Inc. sees FY2012 EPS of $0.57-$0.62, versus the consensus of $0.60. Natus Medical, Inc. sees FY2012 revenue of $256-$262 million, versus the consensus of $260.37 million.

For earnings history and earnings-related data on Natus Medical, Inc. (BABY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Beike (BEKE) PT Raised to $23 at Morgan Stanley